Department of Hematology, Tianjin Medical University General Hospital, China.
J Immunol Res. 2020 Feb 17;2020:4098235. doi: 10.1155/2020/4098235. eCollection 2020.
To explore effects of Epstein-Barr virus (EBV) infection on CD19+ B lymphocytes in patients with immunorelated pancytopenia (IRP).
An enzyme-linked immunosorbent assay (ELISA) in vitro diagnostic kit was used to detect EBV capsid antigen- (CA-) IgG and VCA-IgM antibodies in the serum. We analyzed the EBV-DNA copies of CD19+ B lymphocyte by using real-time quantitative polymerase chain reaction (RT-qPCR). CD21, CD23, CD5, CD80, and CD86 receptors on the surfaces of CD19+ B cells were detected by flow cytometry (FCM). The correlation between these receptors and EBV-DNA copies were evaluated.
The results revealed that the positive rate of EBVCA-IgM and CD19+ B lymphocyte EBV-DNA copy in the IRP group were significantly higher than those in the control group ( < 0.05). CD19+ B lymphocyte EBV-DNA copies were also more abundant in IRP patients than in control subjects ( < 0.05). CD19+ B lymphocyte EBV-DNA copies were also more abundant in IRP patients than in control subjects ( < 0.05). CD19+ B lymphocyte EBV-DNA copies were also more abundant in IRP patients than in control subjects (.
EBV infection may activate CD19+ B lymphocytes and further disrupt bone marrow hematopoiesis in IRP patients.
探讨 EBV 感染对免疫相关性全血细胞减少症(IRP)患者 CD19+B 淋巴细胞的影响。
采用酶联免疫吸附试验(ELISA)体外诊断试剂盒检测血清 EBV 衣壳抗原(CA)-IgG 和 VCA-IgM 抗体,实时荧光定量聚合酶链反应(RT-qPCR)检测 CD19+B 淋巴细胞 EBV-DNA 拷贝数。采用流式细胞术(FCM)检测 CD19+B 细胞表面 CD21、CD23、CD5、CD80 和 CD86 受体,并评估这些受体与 EBV-DNA 拷贝数之间的相关性。
结果显示,IRP 组 EBVCA-IgM 和 CD19+B 淋巴细胞 EBV-DNA 拷贝的阳性率明显高于对照组(<0.05)。IRP 患者的 CD19+B 淋巴细胞 EBV-DNA 拷贝数也明显高于对照组(<0.05)。
EBV 感染可能激活 CD19+B 淋巴细胞,进一步破坏 IRP 患者骨髓造血。